Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Gabriel Silva Marques Borges, Flávia Alves Lima, Guilherme Carneiro, Gisele Assis Castro Goulart & Lucas Antônio Miranda Ferreira. (2021) All-trans retinoic acid in anticancer therapy: how nanotechnology can enhance its efficacy and resolve its drawbacks. Expert Opinion on Drug Delivery 18:10, pages 1335-1354.
Read now
Read now
Takaomi Sanda. (2007) Transcription Factors as Therapeutic Targets in Lymphoid Malignancies. International Reviews of Immunology 26:5-6, pages 305-332.
Read now
Read now
Articles from other publishers (16)
Estefanía García-Guerrero, Luis G. Rodríguez-Lobato, Belén Sierro-Martínez, Sophia Danhof, Stephan Bates, Silke Frenz, Larissa Härtle, Ralph Götz, Markus Sauer, Leo Rasche, K. Martin Kortüm, Jose A. Pérez-Simón, Hermann Einsele, Michael Hudecek & Sabrina R. Prommersberger. (2022) All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells. Haematologica 108:2, pages 568-580.
Crossref
Crossref
Qiang Wang, Zhijuan Lin, Zhuo WangLingqun Ye, Miao XianLiuling XiaoPan SuEnguang BiYung-hsing Huang, Jianfei QianLintao LiuXingzhe MaMaojie YangWei Xiong, Youli Zu, Sai Ravi Pingali, Bing XuQing Yi. (2022) RARγ activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway. Blood 139:1, pages 59-72.
Crossref
Crossref
Mohamed R. Abdelaal, Sameh H. Soror, Mohamed R. Elnagar & Hesham Haffez. (2021) Revealing the Potential Application of EC-Synthetic Retinoid Analogues in Anticancer Therapy. Molecules 26:2, pages 506.
Crossref
Crossref
Gabriel Silva Marques Borges, Micael de Oliveira Ferencs, Cristina de Mello Gomide Loures, Mostafa AL Abdel-Salam, Fernanda Cristina Gontijo Evangelista, Camila Campos Sales, Pedro Henrique Reis da Silva, Renata Barbosa de Oliveira, Ângelo Malachias, Maria Irene Yoshida, Elaine Maria de Souza-Fagundes, Adriano de Paula Sabino, Christian Fernandes & Lucas Antônio Miranda Ferreira. (2020)
Novel self-nanoemulsifying drug-delivery system enhances antileukemic properties of all-
trans
retinoic acid
. Nanomedicine 15:15, pages 1471-1486.
Crossref
Crossref
N. N. Kalitin, Yu. B. Chernykh & I. V. Buravtsova. (2017) Comparative Analysis of Quantitative Parameters of Expression of the Retinoic Acid Nuclear Receptor RARα Gene and APE1/YB-1/MDR1 Pattern Genes in Patients with Newly Detected Multiple Myeloma. Bulletin of Experimental Biology and Medicine 164:1, pages 90-94.
Crossref
Crossref
Alessandra di Masi, Loris Leboffe, Elisabetta De Marinis, Francesca Pagano, Laura Cicconi, Cécile Rochette-Egly, Francesco Lo-Coco, Paolo Ascenzi & Clara Nervi. (2015) Retinoic acid receptors: From molecular mechanisms to cancer therapy. Molecular Aspects of Medicine 41, pages 1-115.
Crossref
Crossref
K. Martin Kortuem, Kaitlyn Zidich, Steven R. Schuster, Meaghan L. Khan, Victor H. Jimenez-Zepeda, Joseph R. Mikhael, Rafael Fonseca & A. Keith Stewart. (2014) Activity of 129 Single-Agent Drugs in 228 Phase I and II Clinical Trials in Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia 14:4, pages 284-290.e5.
Crossref
Crossref
C C Bjorklund, V Baladandayuthapani, H Y Lin, R J Jones, I Kuiatse, H Wang, J Yang, J J Shah, S K Thomas, M Wang, D M Weber & R Z Orlowski. (2013) Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications. Leukemia 28:2, pages 373-383.
Crossref
Crossref
Zhiqiang Liu, Tao Li, Kesheng Jiang, Qiaoli Huang, Yicheng Chen & Feng Qian. (2014) Induction of Chemoresistance by All-Trans Retinoic Acid via a Noncanonical Signaling in Multiple Myeloma Cells. PLoS ONE 9:1, pages e85571.
Crossref
Crossref
Mohsen Malehmir, Vahid Haghpanah, Bagher Larijani, Shahin Ahmadian, Kamran Alimoghaddam, Ramin Heshmat, Ardeshir Ghavamzadeh, Khadijeh Adabi & Seyed H. Ghaffari. (2011) Multifaceted suppression of aggressive behavior of thyroid carcinoma by all-trans retinoic acid induced re-differentiation. Molecular and Cellular Endocrinology.
Crossref
Crossref
Siqing Wang, Guido Tricot, Lei Shi, Wei Xiong, Zhaoyang Zeng, Hongwei Xu, Maurizio Zangari, Bart Barlogie, John D. ShaughnessyJrJr & Fenghuang Zhan. (2009) RARα2 expression is associated with disease progression and plays a crucial role in efficacy of ATRA treatment in myeloma. Blood 114:3, pages 600-607.
Crossref
Crossref
Tomoya Fukui, Yasuo Kodera, Kazuto Nishio, Noriyuki Masuda, Tomohide Tamura & Fumiaki Koizumi. (2009) Synergistic interactions between the synthetic retinoid tamibarotene and glucocorticoids in human myeloma cells. Cancer Science 100:6, pages 1137-1143.
Crossref
Crossref
Åse Ertesvåg, Soheil Naderi & Heidi Kiil Blomhoff. (2009) Regulation of B cell proliferation and differentiation by retinoic acid. Seminars in Immunology 21:1, pages 36-41.
Crossref
Crossref
Enrico Garattini, Maurizio Gianni'Mineko Terao. 2007. Vitamin A. Vitamin A
301
354
.
T Sanda, T Kuwano, S Nakao, S Iida, T Ishida, H Komatsu, K Shudo, M Kuwano, M Ono & R Ueda. (2005) Antimyeloma effects of a novel synthetic retinoid Am80 (Tamibarotene) through inhibition of angiogenesis. Leukemia 19:6, pages 901-909.
Crossref
Crossref
. (2004) Current Awareness in Hematological Oncology. Hematological Oncology 22:2, pages 73-84.
Crossref
Crossref